Literature DB >> 17765026

Proteolytic processing and polarized secretion of tartrate-resistant acid phosphatase is altered in a subpopulation of metaphyseal osteoclasts in cathepsin K-deficient mice.

Serhan Zenger1, Karin Hollberg, Jenny Ljusberg, Maria Norgård, Barbro Ek-Rylander, Riku Kiviranta, Göran Andersson.   

Abstract

Tartrate-resistant acid phosphatase (TRAP) is an enzyme highly expressed in osteoclasts and thought to participate in osteoclast-mediated bone turnover. Cathepsin K (Ctsk) is the major collagenolytic cysteine proteinase expressed in osteoclasts and has recently been shown to be able to proteolytically process and activate TRAP in vitro. In this study, 4-week-old Ctsk(-/-) mice were analysed for TRAP expression at the mRNA, protein and enzyme activity levels to delineate a role of cathepsin K in TRAP processing in osteoclasts in vivo. The absence of cathepsin K in osteoclasts was associated with increased expression of TRAP mRNA, monomeric TRAP protein and total TRAP activity. Proteolytic processing of TRAP was not abolished but prematurely arrested at an intermediate stage without changing enzyme activity, a finding confirmed with RANKL-differentiated osteoclast-like cell line RAW264.7 treated with the cysteine proteinase inhibitor E-64. Thus, the increase in total TRAP activity was mainly due to increased cellular content of monomeric TRAP. The increase in monomeric TRAP expression was more pronounced in osteoclasts of the distal compared to the proximal part of the metaphyseal trabecular bone, suggesting a site-dependent role for cathepsin K in TRAP processing. Moreover, intracellular localization of monomeric TRAP was altered in distal metaphyseal osteoclasts from Ctsk(-/-) mice. Additionally, TRAP was secreted into the ruffled border as the processed form in osteoclasts of Ctsk(-/-) mice, unlike in osteoclasts from wild-type mice which secreted TRAP to the resorption lacuna as the monomeric form. The results demonstrate that cathepsin K is not only involved in proteolytic processing but also affects the intracellular trafficking of TRAP, particularly in osteoclasts of the distal metaphysis. However, contribution by other yet unidentified protease(s) to TRAP processing must also be invoked since proteolytic cleavage of TRAP is not abolished in Ctsk(-/-) mice. Importantly, this study highlights functional differences between bone-resorbing clasts within the trabecular metaphyseal bone, suggesting potentially important differences in the regulation of differentiation and activation depending on the precise anatomical localization of the clast population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17765026     DOI: 10.1016/j.bone.2007.07.010

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  22 in total

1.  Macrophage cathepsin K promotes prostate tumor progression in bone.

Authors:  M K Herroon; E Rajagurubandara; D L Rudy; A Chalasani; A L Hardaway; I Podgorski
Journal:  Oncogene       Date:  2012-05-21       Impact factor: 9.867

2.  Retinoids stimulate periosteal bone resorption by enhancing the protein RANKL, a response inhibited by monomeric glucocorticoid receptor.

Authors:  H Herschel Conaway; Amir Pirhayati; Emma Persson; Ulrika Pettersson; Olle Svensson; Catharina Lindholm; Petra Henning; Jan Tuckermann; Ulf H Lerner
Journal:  J Biol Chem       Date:  2011-06-29       Impact factor: 5.157

3.  Intermittent Parathyroid Hormone Enhances Cancellous Osseointegration of a Novel Murine Tibial Implant.

Authors:  Xu Yang; Benjamin F Ricciardi; Aleksey Dvorzhinskiy; Caroline Brial; Zachary Lane; Samrath Bhimani; Jayme C Burket; Bin Hu; Alexander M Sarkisian; F Patrick Ross; Marjolein C H van der Meulen; Mathias P G Bostrom
Journal:  J Bone Joint Surg Am       Date:  2015-07-01       Impact factor: 5.284

4.  Differential expression of tartrate-resistant acid phosphatase isoforms 5a and 5b by tumor and stromal cells in human metastatic bone disease.

Authors:  Serhan Zenger; Wentao He; Barbro Ek-Rylander; Daphne Vassiliou; Rickard Wedin; Henrik Bauer; Göran Andersson
Journal:  Clin Exp Metastasis       Date:  2010-10-22       Impact factor: 5.150

5.  Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation.

Authors:  Sutada Lotinun; Riku Kiviranta; Takuma Matsubara; Jorge A Alzate; Lynn Neff; Anja Lüth; Ilpo Koskivirta; Burkhard Kleuser; Jean Vacher; Eero Vuorio; William C Horne; Roland Baron
Journal:  J Clin Invest       Date:  2013-01-16       Impact factor: 14.808

6.  Fluid pressure and flow as a cause of bone resorption.

Authors:  Anna Fahlgren; Mathias P G Bostrom; Xu Yang; Lars Johansson; Ulf Edlund; Fredrik Agholme; Per Aspenberg
Journal:  Acta Orthop       Date:  2010-08       Impact factor: 3.717

7.  Treatment with soluble bone morphogenetic protein type 1A receptor fusion protein alleviates irradiation-induced bone loss in mice through increased bone formation and reduced bone resorption.

Authors:  Shen Wang; Jie Li; Huabei Sun; Liangwei Sha; Yilong Guo; Guanqiu Gu; Jiling Mao; Xinfa Nie; Ying Zhai; Dehong Yu; Juan Zhai; Hongnian Li; Xin Shan; Chengbai Dai; Xiangzhi Wu; Xiaobo He; Li Xin; Jun Liu; Ke Heng; Qinghe Geng
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

8.  HCO3-/Cl- anion exchanger SLC4A2 is required for proper osteoclast differentiation and function.

Authors:  Jing Wu; Laurie H Glimcher; Antonios O Aliprantis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-29       Impact factor: 11.205

9.  Jaw and long bone marrows have a different osteoclastogenic potential.

Authors:  Ana Paula de Souza Faloni; Ton Schoenmaker; Azin Azari; Eduardo Katchburian; Paulo S Cerri; Teun J de Vries; Vincent Everts
Journal:  Calcif Tissue Int       Date:  2010-09-23       Impact factor: 4.333

10.  Osteoclast fusion and fission.

Authors:  Ineke D C Jansen; Jenny A F Vermeer; Veerle Bloemen; Jan Stap; Vincent Everts
Journal:  Calcif Tissue Int       Date:  2012-04-25       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.